Given the above findings, we hypothesized increased cell killing by IFN-I-treated PM21-NK cells could be partly attributed to decreased IFN-γ release and the associated decreased induction of NK inhibitory ligands on tumor cells. The gene discussed is IFNG; the disease is neoplasm.